Adherence to antiretroviral therapy

Journal of Association of Physicians of India

Volumn 60, Issue 12, 2012, Pages 16-20

  Gokarn, Anant ^a   Narkhede, Meenakshi Gangadhar ^b   Pardeshi, Geeta Shrikar ^b   Doibale, Mohan Kondiba ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Government Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADDICTION; ADULT; AGE; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; MEMORY; TRAVEL;

ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MEMORY; SUBSTANCE-RELATED DISORDERS; TRAVEL;

EID: 84871204905     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Adherence to antiretroviral therapy in adults, A guide for trainers; Horizons/Population Council International centre for reproductivehealth, Coast Province General Hospital, Mombasa (Ministry of Health, Kenya). www.popcouncil.com
2. Adherence to long-term therapies - Evidence for action. Geneva: World Health Organization; 2003.
3. Pujari S, Patel A, Gangakhedkar R, Kumarswamy N, Gupta S.B. Guidelines for Use of Antiretroviral Therapy for HIV Infected Individuals in India (ART Guidelines 2008). Journal of Assoc Physicians India 2008;56:339-367.
4. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
5. Sarna A, Pujari S, Sengar A.K, Garg R, Van Dam J. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36.
6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
7. Morisky DE, Ward HJ, Liu K-Y. Self-reported Medication Taking Behaviour: A valid Indicator for assessing compliance. Presentation at the 129th American Public Health Association Meeting, Atlanta; 2001
8. Sodergard B, Halvarsson M, Tully M. P, Mindouri S, Nordstrom L, Lindback S, Sonnerborg A, Kettis Lindblad A. Adherence to treatment in Swedish HIV infected patients. Journal of Clinical Pharmacy and Therapeutics 2006;31:605-616.
9. Viswanathan H, Anderson R, Thomas J, 3rd. Nature and correlates of SF-12 physical and mental quality of life components among low-income HIV adults using an HIV service center. Qual Life Res 2005;14:935-944.
10. Viswanathan H, Anderson R, Thomas J, 3rd. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Pat Care STDS 2005;19:306-316.
11. Sodergard B, Halvarsson M, Brannstrom J, et al. A comparison between AACTG Adherence Questionnaire and the 9-item Morisky Medication Adherence Scale in HIV-patients. Eighth International Congress on Drug Therapy in HIV Infection, Glasgow, UK; 2006.
12. Schneider J, Kaplan SH, Greenfield S, et al. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-1103.
13. Sarna A, Pujari S, Sengar A.K, Garg R, Van Dam J. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36.
14. Adherence to long-term therapies - Evidence for action. Geneva: World Health Organization; 2003.
15. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977.
16. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Inf Dis 2001;33:1417-1423.
17. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care 2000;12:405-408.
18. Wanchu A, Kaur R, Bamberry P, Singh S. Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a tertiary centre in North India. AIDS Behav 2007;11:99-102.
19. Markos E, Worku A & Davey G. Adherence to ART in PLWHA at Yirgalem Hospital, South Ethiopia. Ethiopian Journal of Health Development 2008;22:174-179.
20. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIVinfected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004;20:1053-1056.
21. Kumarasamy N. Can we reduce morbidity & mortality due to HIV & stop transmission in India? Indian J Med Res 2005;122:461-463.
22. Turner B J, Laine C, Cosler I, et al. Relationship of Gender, depression, & Health care delivery with antiretroviral adherence in HIV infected drug users. J Gen Intern Med 2003;118:248.
23. Ammassari A, Murri R, Pezzotti P et al. Self-reported symptoms and medication side effects influence adherence to Highly Active Antiretroviral Therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndrome 2001; 28: 445-449.
24. Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS 2004;18:683-688.
25. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004;18:S19-S25.
26. Levine AJ, Hinkin CH, Castellon SA et al. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behavior 2005;9:1-8.
27. Murphy DA, Marelich WD, Hoffman D, Steers WN. Predictors of antiretroviral adherence. AIDS Care 2004;16:471-484.
28. Moralez, R., Figueiredo, V.M., Sinkoc, M.C.B., Gallani, C. & Tomazin, S.L. Adherence of patients with AIDS to treatment with HAART medications: Difficulties related and proposition of attenuating measures. 12th World AIDS Conference, Geneva, 1998. Abstract 42442.
29. Catz, S., Heckman, T. & Kochman, A. Adherence to HAART therapy among older adults living with HIV disease. 4th International Conference on the Biophysical Aspects of HIV Infection. Canada: Ottawa, 1999
30. Golin CE, Liu Hayes RD et al. A prospective study of the predictors of adherence in combination anti retroviral medication. Gen Intern Med 2002;17:756-765.
31. Stockwell Morris L, Schultz RM. Patient compliance - an overview. J Clin Pharm Therap 1992;17:283-295.
32. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
33. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Pat Care STDS 2002;16:599-608.
34. Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS 2003;17:1925-1932.
35. Carrieri et al. The dynamic of adherence to highly active antiretroviral therapy: Results from the French national APROCO cohort. Journal of Acquired Immune Deficiency Syndromes 2001;28:232-239.
36. Williams, A. & Friedland, G. Adherence, adherence, and HAART. AIDS Clinical Care 1997;9:51-55.
37. Besch, L.C. Compliance in clinical trials. AIDS 1995;9:1-10.
38. Eraker, S.A., Kirscht, J.P. & Becker M.H. Understanding and improving compliance. Annals of Internal Medicine 1984;100:258-268.
39. Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002;54:1481-1496.